StockData
Stereotaxis, Inc. logo

Stereotaxis, Inc. (STXS) stock

STXSNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/3018% below fair value
$0.95+0.06 (+7.26%)

Close on Nov 18, 2026Market cap $94.80MP/E –Yield –

Stereotaxis operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Stereotaxis's operating income for the twelve months ending Jun 30, 2026 was -$22.76M. For fiscal 2025 it was -$22.11M. The highest annual figure on record is -$2.46M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$22.11M–
FY2024Dec 31, 2024-$24.74M–
FY2023Dec 31, 2023-$21.84M–
FY2022Dec 31, 2022-$18.78M–
FY2021Dec 31, 2021-$12.89M–
FY2020Dec 31, 2020-$6.71M–
FY2019Dec 31, 2019-$4.83M–
FY2018Dec 31, 2018-$2.46M–
FY2017Dec 31, 2017-$5.92M–
FY2016Dec 31, 2016-$6.43M–
FY2015Dec 31, 2015-$5.41M–
FY2014Dec 31, 2014-$5.38M–
FY2013Dec 31, 2013-$8.84M–
FY2012Dec 31, 2012-$10.63M–
FY2011Dec 31, 2011-$31.94M–
FY2010Dec 31, 2010-$18.96M–
FY2009Dec 31, 2009-$23.84M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$4.57M–
Q1 FY2026Mar 31, 2026-$5.98M–
Q4 FY2025Dec 31, 2025-$5.65M–
Q3 FY2025Sep 30, 2025-$6.56M–
Q2 FY2025Jun 30, 2025-$3.98M–
Q1 FY2025Mar 31, 2025-$5.93M–
Q4 FY2024Dec 31, 2024-$7.63M–
Q3 FY2024Sep 30, 2024-$6.35M–
Q2 FY2024Jun 30, 2024-$6.02M–
Q1 FY2024Mar 31, 2024-$4.75M–
Q4 FY2023Dec 31, 2023-$5.30M–
Q3 FY2023Sep 30, 2023-$5.64M–
Q2 FY2023Jun 30, 2023-$5.28M–
Q1 FY2023Mar 31, 2023-$5.62M–
Q4 FY2022Dec 31, 2022-$4.46M–
Q3 FY2022Sep 30, 2022-$5.05M–
Q2 FY2022Jun 30, 2022-$5.18M–
Q1 FY2022Mar 31, 2022-$4.09M–
Q4 FY2021Dec 31, 2021-$3.35M–
Q3 FY2021Sep 30, 2021-$4.62M–
Q2 FY2021Jun 30, 2021-$3.39M–
Q1 FY2021Mar 31, 2021-$1.53M–
Q4 FY2020Dec 31, 2020-$1.18M–
Q3 FY2020Sep 30, 2020-$1.56M–
Q2 FY2020Jun 30, 2020-$1.92M–
Q1 FY2020Mar 31, 2020-$2.05M–
Q4 FY2019Dec 31, 2019-$1.19M–
Q3 FY2019Sep 30, 2019-$41.21K–
Q2 FY2019Jun 30, 2019-$1.46M–
Q1 FY2019Mar 31, 2019-$2.14M–
Q4 FY2018Dec 31, 2018-$586.68K–
Q3 FY2018Sep 30, 2018-$113.78K-167.8%
Q2 FY2018Jun 30, 2018-$626.06K–
Q1 FY2018Mar 31, 2018-$1.13M–
Q4 FY2017Dec 31, 2017-$3.75M–
Q3 FY2017Sep 30, 2017$167.80K–
Q2 FY2017Jun 30, 2017-$434.78K–
Q1 FY2017Mar 31, 2017-$1.90M–
Q4 FY2016Dec 31, 2016-$2.13M–
Q3 FY2016Sep 30, 2016-$1.17M–

More Stereotaxis figures

See a number that looks wrong?